Amundi

SEC CIK: 0001330387
Latest filing: Aug 26, 2026

SEC filings (opens in a new tab)

SYRE holding history

Spyre Therapeutics, Inc. in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SYRE overview All 13F holders of SYRE Full Q2 2026 holdings

Shares (Q2 2026): 2,793
Value: $248.0K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2024

Holdings of SYRE by Amundi, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	2,793	$248.0K	<0.1%	+2,793	New	Holders
Q2 2025	0	$0	0.0%	−5−100.0%	Sold out	Holders
Q1 2025	5	$70	<0.1%	−27−84.4%	Reduced	Holders
Q4 2024	32	$769	<0.1%	+32	New	Holders